CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | Griffin Stephen D. EVP, CFO & COO | Shares withheld for taxes | −3,769 | $11.59 | $44K | 9,871 |
| 2025-06-03 | Griffin Stephen D. EVP, CFO & COO | Option exercise · Restricted Stock Unit | +12,840 | 25,680 | ||
| 2025-03-17 | Nunes Anne SVP, Chief Operations Officer | Option exercise | +3,637 | 21,722 | ||
| 2025-03-17 | Nunes Anne SVP, Chief Operations Officer | Shares withheld for taxes | −1,068 | $15.91 | $17K | 20,654 |
| 2025-03-17 | Nunes Anne SVP, Chief Operations Officer | Option exercise · Restricted Stock Unit | −3,637 | 7,275 | ||
| 2025-03-17 | Colleran David EVP, General Counsel, Corp Sec | Option exercise | +6,448 | 49,847 | ||
| 2025-03-17 | Colleran David EVP, General Counsel, Corp Sec | Shares withheld for taxes | −1,893 | $15.91 | $30K | 47,954 |
| 2025-03-17 | Colleran David EVP, General Counsel, Corp Sec | Option exercise · Restricted Stock Unit | −6,448 | 12,897 | ||
| 2025-03-17 | Blanchard Cheryl R President, CEO, Director | Option exercise | +25,132 | 209,472 | ||
| 2025-03-17 | Blanchard Cheryl R President, CEO, Director | Shares withheld for taxes | −12,152 | $15.91 | $193K | 197,320 |
| 2025-03-17 | Blanchard Cheryl R President, CEO, Director | Option exercise · Restricted Stock Unit | −25,132 | 50,263 | ||
| 2025-03-14 | Nunes Anne SVP, Chief Operations Officer | Grant or award · Restricted Stock Unit | +20,761 | 20,761 | ||
| 2025-03-14 | Nunes Anne SVP, Chief Operations Officer | Grant or award · Restricted Stock Unit | +4,650 | 4,650 | ||
| 2025-03-14 | Griffin Stephen D. EVP, CFO and Treasurer | Grant or award · Restricted Stock Unit | +38,473 | 38,473 | ||
| 2025-03-14 | Griffin Stephen D. EVP, CFO and Treasurer | Grant or award · Restricted Stock Unit | +18,672 | 18,672 | ||
| 2025-03-14 | Colleran David EVP, General Counsel, Corp Sec | Grant or award · Restricted Stock Unit | +28,165 | 28,165 | ||
| 2025-03-14 | Colleran David EVP, General Counsel, Corp Sec | Grant or award · Restricted Stock Unit | +13,669 | 13,669 | ||
| 2025-03-14 | Blanchard Cheryl R President, CEO, Director | Grant or award · Restricted Stock Unit | +73,559 | 73,559 | ||
| 2025-03-14 | Blanchard Cheryl R President, CEO, Director | Grant or award · Restricted Stock Unit | +71,403 | 71,403 | ||
| 2025-03-11 | Nunes Anne SVP, Chief Operations Officer | Option exercise | +2,561 | 18,837 |
Page 4 of 20 · 400 trades